The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression by Ilias Tsochantaridis, Angelos Roupas, Sofie Mohlin, Aglaia Pappa, Georgia-Persephoni Voulgaridou

Get full text

Cell types or cell states? An investigation of adrenergic and mesenchymal cell phenotypes in neuroblastoma by Anuraag Bukkuri, Stina Andersson, Marina S. Mazariegos, Joel S. Brown, Emma U. Hammarlund, Sofie Mohlin

Get full text

Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma by Sinan Karakaya, Lisa Gunnesson, Erik Elias, Paula Martos-Salvo, Mercedes Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin

Get full text

Erratum To: Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma by Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco‐Aparicio, Cristian Garcia‐Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer von Stedingk, Daniel Bexell

Get full text

Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma by Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco‐Apiricio, Cristian Garcia‐Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer von Stedingk, Daniel Bexell

Get full text